1st Quarter - Report

AVENUE SOLUTIONS for GENENTECH USA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicare Part B, CMS coverage and reimbursement; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act; Issues related to Medicaid Drug Rebate Program

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5378 (118th), S. 2973 (118th)

Health Issues HCR

Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to 340b drug pricing program; Expiring healthcare extenders; S. 1339, The Pharmacy Benefit Manager Reform Act; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47); Issues related to 340b

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2882 (118th), H.R. 4366 (118th), S. 1339 (118th)

Homeland Security HOM

Issues related to biosecurity

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.